Osteoarthritis Trial, Recruiting NCT07678996 Sponsor: Kayseri City Hospital Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07678996
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 40 and 75 years old and have been diagnosed with knee osteoarthritis by a doctor using recognized medical guidelines.
  • Your knee osteoarthritis has been rated as moderate in severity based on X-ray results (confirm with trial site).
  • You have had ongoing knee pain for more than 6 months.
  • Your knee pain rates at 3 or higher out of 10 when you are doing activities that put weight on your knee, such as walking or climbing stairs.

Who may not be able to join:

  • You have, or have had, a serious knee infection, a major knee injury, or a type of arthritis caused by inflammation (such as rheumatoid arthritis).
  • You have had a broken bone in your knee or knee surgery in the past 6 months.
  • You have had any injections into your knee joint (such as steroid, hyaluronic acid, or PRP injections) in the past 6 months.
  • You have received physiotherapy or rehabilitation for your knee in the past 6 months.
  • You have a bone infection near the knee, a blood infection, or bleeding into the knee joint.
  • You have had or currently have cancer affecting your leg.
  • You have a known allergy or sensitivity to medical ozone.
  • You have severe anaemia, a low platelet count, a bleeding disorder, or you take blood-thinning medication.
  • You are pregnant or currently breastfeeding.
  • You have an active infection anywhere in your body.
  • You have a serious ongoing health condition, such as advanced heart or lung disease, or diabetes that is not well controlled.
  • You have an overactive thyroid or a progressive condition affecting your muscles or nerves.
  • You have difficulties with memory, thinking, or understanding that would make it hard to follow the study procedures (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905072387257

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kayseri City Hospital
Registry
ClinicalTrials.gov
Start date
19 November 2025
Est. completion
30 November 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Numerical Rating Scale at Third Month after the last ozone injection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov